期刊文献+

循环miRNAs作为肝损伤的新型生物标志物的研究进展

Recent progress toward the use of circulating microRNAs as a novel biomarkers of liver injury
原文传递
导出
摘要 急、慢性肝损伤严重威胁人群健康。MicroRNAs(miRNAs)与人类多种疾病相关联,是多种细胞增殖过程的重要调控因素。近年来,miRNAs还被认为是反映细胞损伤的一种重要生物标志物。miRNAs具有细胞特异性,能在细胞损伤的时候被释放到胞外,成为循环miRNAs,这为液体活检提供了可能。笔者综述了循环miRNAs特点、来源以及在药物性肝损伤、病毒性肝损伤和非酒精性脂肪肝类疾病中做为标志物的研究现状,同时展望了该领域的研究方向。 Both acute and chronic liver injury represent serious threat to huam health.MicroRNAs(miRNAs)have been shown to be critical mediators of many cellular and developmental processes and have been implicated in different human diseases.MicroRNAs have emerged in recent years as a promising new class of biomarker for monitoring injury.Mi RNAs are cell-type specific and are released during injury,called circulating miRNAs,thus liquid biopsy may be obtained by sampling extra cellular fluids.In this paper,the characteristics and source of circulating miRNAs,the current state of circulating miRNAs biomarkers for drug-induced liver injury,viral hepatitis injury and non-alcoholic fatty liver disease are reviewed,and the current research directions in the field are discussed also.
作者 周殿明 钱智勇 ZHOU Dian-ming;QIAN Zhi-yong(Department of Toxicology,Tianjin Centers for Disease Control and Prevention,Tianjin 300011,China)
出处 《环境与健康杂志》 CAS 北大核心 2021年第3期275-278,共4页 Journal of Environment and Health
关键词 循环miRNA 生物标志物 肝损伤 Circulating miRNAs Biomarker Liver injury
  • 相关文献

参考文献2

二级参考文献44

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2Nobili V, Alkhouri N, Alisi A, Della Corte C, Fitzpatrick E, RaponiM, Dhawan A. Nonalcoholic fatty liver disease: a challenge for pediatricians. JAMA Pediatr 2015; 169: 170-176 [PMID: 25506780DOI: 10.1001/jamapediatrics.2014.2702].
  • 3Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, ContrerasM, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liverdisease and nonalcoholic steatohepatitis among a largely middleagedpopulation utilizing ultrasound and liver biopsy: a prospectivestudy. Gastroenterology 2011; 140: 124-131 [PMID: 20858492DOI: 10.1053/j.gastro.2010.09.038].
  • 4Anstee QM, Targher G, Day CP. Progression of NAFLD todiabetes mellitus, cardiovascular disease or cirrhosis. Nat RevGastroenterol Hepatol 2013; 10: 330-344 [PMID: 23507799 DOI:10.1038/nrgastro.2013.41].
  • 5Vernon G, Baranova A, Younossi ZM. Systematic review: theepidemiology and natural history of non-alcoholic fatty liver diseaseand non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther2011; 34: 274-285 [PMID: 21623852 DOI: 10.1111/j.1365-2036.2011.04724.x].
  • 6Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histologyin obese patients undergoing bariatric surgery. J Hepatol 2006; 45:600-606 [PMID: 16899321].
  • 7Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E,Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and itsconnection with insulin resistance, dyslipidemia, atherosclerosisand coronary heart disease. Nutrients 2013; 5: 1544-1560 [PMID:23666091 DOI: 10.3390/nu5051544].
  • 8Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA,Younossi ZM, Ahmed A. Nonalcoholic steatohepatitis is the secondleading etiology of liver disease among adults awaiting livertransplantation in the United States. Gastroenterology 2015; 148:547-555 [PMID: 25461851 DOI: 10.1053/j.gastro.2014.11.039].
  • 9Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, HuiJM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, WeltmanM, George J. NASH and insulin resistance: Insulin hypersecretionand specific association with the insulin resistance syndrome.Hepatology 2002; 35: 373-379 [PMID: 11826411].
  • 10Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A,Erbel R, Blankstein R, Feldman T, Al-Mallah MH, Santos RD,Budoff MJ, Nasir K. A systematic review: burden and severity ofsubclinical cardiovascular disease among those with nonalcoholicfatty liver; should we care- Atherosclerosis 2013; 230: 258-267[PMID: 24075754 DOI: 10.1016/j.atherosclerosis.2013.07.052].

共引文献338

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部